Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Icahn Capital Praises Xerox Corp (XRX) Split in Filing, Lands Board Seats

Page 1 of 16

At Insider Monkey, we closely monitor the moves made by activist investors, and Carl Icahn of Icahn Capital LP is without a doubt the most prominent of those. Icahn Capital recently filed a 13D related to its Xerox Corp (NYSE:XRX) holding, in which the firm disclosed a number of things, including a change to its holding and an agreement reached with Xerox following the company’s decision to split into two businesses, which was announced this morning. As part of the agreement, Icahn Capital will land a trio of board seats. You can see the main filing below, as well as access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
High River Limited Partnership 18,475,408 0 18,475,408 0 18,475,408 1.82%
Hopper Investments LLC 0 18,475,408 0 18,475,408 18,475,408 1.82%
Barberry Corp. 0 18,475,408 0 18,475,408 18,475,408 1.82%
Icahn Partners Master Fund LP 30,708,164 0 30,708,164 0 30,708,164 3.03%
Icahn Offshore LP 0 30,708,164 0 30,708,164 30,708,164 3.03%
Icahn Partners LP 43,193,471 0 43,193,471 0 43,193,471 4.27%
Icahn Onshore LP 0 43,193,471 0 43,193,471 43,193,471 4.27%
Icahn Capital LP 0 73,901,635 0 73,901,635 73,901,635 7.30%
IPH GP LLC 0 73,901,635 0 73,901,635 73,901,635 7.30%
Icahn Enterprises Holdings L.P. 0 73,901,635 0 73,901,635 73,901,635 7.30%
Icahn Enterprises G.P. Inc. 0 73,901,635 0 73,901,635 73,901,635 7.30%
Beckton Corp. 0 73,901,635 0 73,901,635 73,901,635 7.30%
Carl C. Icahn 0 92,377,043 0 92,377,043 92,377,043 9.12%
Date of Transaction Amount of Securities Price Per Share High River Limited Partnership
Carl Icahn
Carl Icahn
Icahn Capital LP

Page 1 of 16 SEC Filing

Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Xerox Corporation
(Name of Issuer)
Common Stock, $1 par value
(Title of Class of Securities)
(CUSIP Number)
Jesse Lynn, Esq.
Icahn Capital LP
767 Fifth Avenue, 47th Floor
New York, New York 10153
(212) 702-4300
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
January 28, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /.
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d‑7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Xerox Corp (NYSE:XRX)
Trade (NYSE:XRX) Now!
Page 1 of 16

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!